Evidence map›Paper›PMID 28006686›Full record

ArticleBiosensors & bioelectronics2017

Automated microraft platform to identify and collect non-adherent cells successfully gene-edited with CRISPR-Cas9.

Peter J Attayek, Jennifer P Waugh, Sally A Hunsucker, Philip J Grayeski, Christopher E Sims, Paul M Armistead, Nancy L Allbritton

Abstract read
In one paragraph

Article in Biosensors & bioelectronics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Microraft arrays for serial-killer CD19 chimeric antigen receptor T cells and single cell isolation.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Image-Based Live Cell Sorting.Trends in biotechnology · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Platforms for Single-Cell Collection and Analysis.International journal of molecular sciences · 2018
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peter J AttayekDepartment of Biomedical Engineering, University of North Carolina, Chapel Hill NC and North Carolina State University, Raleigh, NC, United States.
Jennifer P WaughDepartment of Medicine, University of North Carolina, Chapel Hill, NC, United States.
Sally A HunsuckerLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
Philip J GrayeskiDepartment of Medicine, University of North Carolina, Chapel Hill, NC, United States.
Christopher E SimsDepartment of Medicine, University of North Carolina, Chapel Hill, NC, United States; Department of Chemistry, University of North Carolina, Chapel Hill, NC, United States.
Paul M ArmisteadDepartment of Medicine, University of North Carolina, Chapel Hill, NC, United States; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
Nancy L AllbrittonDepartment of Biomedical Engineering, University of North Carolina, Chapel Hill NC and North Carolina State University, Raleigh, NC, United States; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States; Department of Chemistry, University of North Carolina, Chapel Hill, NC, United States. Electronic address: nlallbri@unc.edu.

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Generation of a Gene-Targeted Human iPS Cell Library for Macular DegenerationR01EY024556 · NEI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ALLBRITTON, NANCY L. · 2014 to 2018
$2.9M
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell ImmunotherapyR01CA201225 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ARMISTEAD, PAUL MICHAEL · 2016 to 2020
$2.3M
The CellRaft AIR System: Workflow Automation for Stem Cell Isolation and RecoveryR42GM106421 · NIGMS · CELL MICROSYSTEMS, INC. · PI ALLBRITTON, NANCY L. · 2016 to 2017
$1.5M
Optimization of IsoRaft Technology for Stem Cell MarketR43GM106421 · NIGMS · CELL MICROSYSTEMS, INC. · PI DOBES, NICHOLAS CARL · 2013 to 2013
$151k
NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA201225NEI NIH HHS R01 EY024556NIGMS NIH HHS R42 GM106421NIGMS NIH HHS R43 GM106421
6 · The paper itself

Abstract

Microraft arrays have been used to screen and then isolate adherent and non-adherent cells with very high efficiency and excellent viability; however, manual screening and isolation limits the throughput and utility of the technology. In this work, novel hardware and software were developed to automate the microraft array platform. The developed analysis software identified microrafts on the array with greater than 99% sensitivity and cells on the microrafts with 100% sensitivity. The software enabled time-lapse imaging and the use of temporally varying characteristics as sort criteria. The automated hardware released microrafts with 98% efficiency and collected released microrafts with 100% efficiency. The automated system was used to examine the temporal variation in EGFP expression in cells transfected with CRISPR-Cas9 components for gene editing. Of 11,499 microrafts possessing a single cell, 220 microrafts were identified as possessing temporally varying EGFP-expression. Candidate cells (n=172) were released and collected from the microraft array and screened for the targeted gene mutation. Two cell colonies were successfully gene edited demonstrating the desired mutation.

Indexed as

CRISPR-Cas SystemsMutationBiosensing TechniquesEquipment DesignGenes, ReporterGreen Fluorescent ProteinsHumansImage Processing, Computer-AssistedK562 CellsLeukemiaSplicing Factor U2AFTissue Array AnalysisTransfectionenhanced green fluorescent proteinGreen Fluorescent ProteinsSplicing Factor U2AFU2AF1 protein, humanCell arrayCell sortingCRISPR-Cas9CytometryMicroraft

Identifiers

PMID28006686
PMCPMC5323363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.